RCM
ADAP

RA Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

RA Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,499,025
Closed -$13.5M – 83
2020
Q4 		$13.5M Sell
2,499,025
-8,830,556
-78% -$47.6M 0.19% 66
2020
Q3 		$90.4M Sell
11,329,581
-1,722,883
-13% -$13.7M 1.65% 18
2020
Q2 		$131M Buy
13,052,464
+510,576
+4% +$5.11M 2.55% 10
2020
Q1 		$34.1M Buy
+12,541,888
New +$34.1M 1.08% 29